全文获取类型
收费全文 | 3576篇 |
免费 | 642篇 |
国内免费 | 1篇 |
专业分类
各国政治 | 59篇 |
工人农民 | 250篇 |
世界政治 | 92篇 |
外交国际关系 | 322篇 |
法律 | 1810篇 |
中国共产党 | 145篇 |
中国政治 | 570篇 |
政治理论 | 197篇 |
综合类 | 774篇 |
出版年
2023年 | 18篇 |
2022年 | 69篇 |
2021年 | 61篇 |
2020年 | 94篇 |
2019年 | 72篇 |
2018年 | 60篇 |
2017年 | 33篇 |
2016年 | 28篇 |
2015年 | 60篇 |
2014年 | 71篇 |
2013年 | 150篇 |
2012年 | 261篇 |
2011年 | 202篇 |
2010年 | 294篇 |
2009年 | 349篇 |
2008年 | 332篇 |
2007年 | 275篇 |
2006年 | 312篇 |
2005年 | 207篇 |
2004年 | 176篇 |
2003年 | 216篇 |
2002年 | 188篇 |
2001年 | 167篇 |
2000年 | 55篇 |
1999年 | 87篇 |
1998年 | 21篇 |
1997年 | 18篇 |
1996年 | 32篇 |
1995年 | 25篇 |
1994年 | 27篇 |
1993年 | 23篇 |
1992年 | 24篇 |
1991年 | 32篇 |
1990年 | 32篇 |
1989年 | 35篇 |
1988年 | 16篇 |
1987年 | 20篇 |
1986年 | 24篇 |
1985年 | 9篇 |
1984年 | 12篇 |
1983年 | 7篇 |
1982年 | 4篇 |
1981年 | 12篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1974年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有4219条查询结果,搜索用时 0 毫秒
991.
Notes on Contributors
Notes on contributors 相似文献992.
Many different molecular typing methods have been reported to complement routine serological ABO blood typing in forensics. However, these ABO genotyping methods are often time-consuming and call for an initial DNA isolation step that requires the use of expensive kits or reagents. We report here a rapid direct ABO genotyping method that eliminates the need for DNA extraction from fresh blood, hair, and body fluid stains before PCR. Using a fast PCR instrument and an optimized polymerase, the genotyping method-which employs a multiplex allele-specific primer set for the simultaneous detection of three single-nucleotide polymorphism (SNP) sites (nucleotides 261, 526, and 803)-identifies A, B, O01/O02, O03, and cis-AB01 alleles in around 70 min from sample collection to electropherogram. Not only will this ABO genotyping method be efficiently used in forensic practice for rapid screening of samples before full-blown multilocus short tandem repeat profiling, but it will also demonstrate an example of rapid direct genotyping of SNPs that offers the advantages of time- and cost-efficiency, convenience, and reduced contamination during DNA analysis. 相似文献
993.
The Food and Drug Administration (FDA) is amending the final monograph (FM) for over-the-counter (OTC) bronchodilator drug products to add additional warnings (e.g., an "Asthma alert') and to revise the indications, warnings, and directions in the labeling of products containing the ingredients ephedrine, ephedrine hydrochloride, ephedrine sulfate, epinephrine, epinephrine bitartrate, racephedrine hydrochloride, and racepinephrine hydrochloride. FDA is issuing this final rule after considering data and information submitted in response to the Agency's proposed labeling revisions for these products. This final rule is part of FDA's ongoing review of OTC drug products. 相似文献
994.
The Food and Drug Administration (FDA) is amending its regulations to add a new requirement for the display of health warnings on cigarette packages and in cigarette advertisements. This rule implements a provision of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) that requires FDA to issue regulations requiring color graphics, depicting the negative health consequences of smoking, to accompany the nine new textual warning statements required under the Tobacco Control Act. The Tobacco Control Act amends the Federal Cigarette Labeling and Advertising Act (FCLAA) to require each cigarette package and advertisement to bear one of nine new textual warning statements. This final rule specifies the color graphic images that must accompany each of the nine new textual warning statements. 相似文献
995.
This final rule will implement section 2702 of the Patient Protection and Affordable Care Act which directs the Secretary of Health and Human Services to issue Medicaid regulations effective as of July 1, 2011 prohibiting Federal payments to States under section 1903 of the Social Security Act for any amounts expended for providing medical assistance for health care-acquired conditions specified in the regulation. It will also authorize States to identify other provider-preventable conditions for which Medicaid payment will be prohibited. 相似文献
996.
The Food and Drug Administration (FDA) is classifying the contact cooling system for aesthetic use into class II (special controls). The special control that will apply to the device is the guidance document entitled "Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Contact Cooling System for Aesthetic Use." The Agency is classifying the device into class II (special controls) in order to provide reasonable assurance of safety and effectiveness of the device. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of a guidance document that will serve as the special control for this device type. 相似文献
997.
The Food and Drug Administration (FDA) is reclassifying the topical oxygen chamber for extremities (TOCE) from class III to class II. This device is intended to surround a patient's limb and apply humidified oxygen topically at a pressure slightly greater than atmospheric pressure to aid healing of chronic skin ulcers, such as bedsores. This reclassification is on the Secretary of Health and Human Services's own initiative based on new information. This action is being taken under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) as amended by the Medical Device Amendments of 1976 (the 1976 Amendments), the Safe Medical Devices Act of 1990 (the SMDA), and the Food and Drug Administration Modernization Act of 1997 (FDAMA). Elsewhere in this issue of the Federal Register, FDA is announcing the availability of the guidance document entitled ``Class II Special Controls Guidance Document: Topical Oxygen Chamber for Extremities,' which will serve as the special control for this device. 相似文献
998.
The Food and Drug Administration (FDA) is classifying the low level laser system for aesthetic use into class II (special controls). The special control(s) that will apply to the device is entitled ``Class II Special Controls Guidance Document: Low Level Laser System for Aesthetic Use.' The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of a guidance document that will serve as the special control for this device type. 相似文献
999.
The Food and Drug Administration (FDA) is announcing the re-establishment of the Medical Imaging Drugs Advisory Committee in FDA's Center for Drug Evaluation and Research. This rule amends the current language for the Medical Imaging Drugs Advisory Committee in the Agency's list of standing advisory committees in FDA's regulations. 相似文献
1000.
Indirekte Landnutzungs?nderungen beim Anbau von Energiepflanzen k?nnen die Treibhausgasminderungsbilanz
von Energie aus Biomasse herabsetzen und Biodiversit?t sowie Boden- und Wasserressourcen beeintr?chtigen.
Um derartige Effekte in rechtliche Regelungen über die Nachhaltigkeit von Bioenergie einzubeziehen,
wurden verschiedene Ans?tze vorgeschlagen. Eine überzeugende Methodologie steht bis heute jedoch
noch nicht zur Verfügung. Der Beitrag gibt einen überblick über die diskutierten Methoden,
bietet eine vergleichende Bewertung und leitet hieraus rechtspolitische Empfehlungen ab. 相似文献